ArticleMagyar onkologia2026
[Dosimetric comparison of model-based and conventional calculation algorithms in high-dose-rate brachytherapy of head and neck tumours].
Article in Magyar onkologia, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
aimTo investigate the effect of a model-based calculation algorithm that takes into account tissue inhomogeneities and real scattering conditions, on dose-volume parameters in brachytherapy for head and neck tumours.
methodsWe recalculated the treatment plans of twentyfour patients treated with brachytherapy using the modelbased Advanced Collapsed Cone Engine (ACE) algorithm. High-dose volumes in the target and volumes irradiated with lower doses were determined. We calculated the doses to the organs at risk for the small volumes receiving high doses and the average doses.
resultsThe conventional calculation algorithm calculated higher doses than ACE for almost all parameters. The difference was less than 1% for V100 and D90. Among the volumes enclosed by the isodose surfaces, the difference was greater between the high-dose volumes and the low-dose volumes. The doses to the mandible were 2-3% lower with ACE, while the doses to the skin were 4-7% lower. The difference to the salivary glands was between 5-8%, while the doses to the spinal cord were the same.
conclusionsWhen treating head and neck tumours, the traditional calculation algorithm overestimates the doses to the target volume and organs at risk. The introduction of the new calculation algorithm into clinical practice is not yet recommended.
Indexed as
Identifiers
41819060PMC12990080What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.